Ataprost

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAtaprost
Drug Alias NameAtaprostTepoprostenolONO-41483OP-41483
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid IP receptor agonists
TargetsProstanoid IP receptor
Therapy Area/IndicationsArterial Occlusive DiseasesMyocardial IschemiaHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOno Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsArterial Occlusive DiseasesMyocardial IschemiaHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A